(Q48384103)

11 February 2018

http://europepmc.org/abstract/MED/24352148

editorial

0 references

title

Molecular insights provide the critical path to disease mitigation (English)

1 reference

11 February 2018

http://europepmc.org/abstract/MED/24352148

author

Scott A. Waldman

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24352148%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

A Terzic

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24352148%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

language of work or name

English

0 references

publication date

1 January 2014

1 reference

11 February 2018

http://europepmc.org/abstract/MED/24352148

published in

Clinical Pharmacology & Therapeutics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24352148%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24352148%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24352148%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

3-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24352148%20AND%20SRC:MED&resulttype=core&format=json

Network-based approaches in drug discovery and early development

11 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.211

Systems-based discovery advances drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.211

Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.211

Connecting the dots: applications of network medicine in pharmacology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.211

Integration of pharmacometabolomic and pharmacogenomic approaches reveals novel insights into antiplatelet therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.211

Genomic medicine, precision medicine, personalized medicine: what's in a name?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.211

Acceleration of drug development: a collaboration of many stakeholders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.211

A health-care system perspective on implementing genomic medicine: pediatric acute lymphoblastic leukemia as a paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.211

Treatment of BRAF-mutant melanoma: the role of vemurafenib and other therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.211

Computation as the mechanistic bridge between precision medicine and systems therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.211

Novel immunomodulatory approaches for the management of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.211

Current status of targeted therapy for anaplastic lymphoma kinase-rearranged non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.211

Defining "innovativeness" in drug development: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.211

The value proposition of molecular medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.211

Translational medicine individualizes healthcare discovery, development and delivery. Foreword.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.211

Biomarker-driven therapeutic management of Alzheimer's disease: establishing the foundations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.211

A map of Alzheimer's disease-signaling pathways: a hope for drug target discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.211

Antiobesity pharmacotherapy: new drugs and emerging targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.211

Interpreting networks in systems biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.211

inferred from DOI database lookup

7 January 2021

based on heuristic

Prospects for rapid advances in the development of new medicines for special medical needs

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.211

inferred from DOI database lookup

7 January 2021

based on heuristic

Knowledge cycle transforms therapeutic innovation

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.211